Biodefense Market to grow at 6.9% CAGR from 2016 to 2024

1
Global Biodefense Market to grow at 6.9 CAGR
from 2016 to 2024Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Biodefense Market

• Global Biodefense Market size contribution was
  9.8 billion for 2015 with CAGR of 6.91
  predicted to be registered for forecast timeline.
  
• Rising bioterrorism threat and government support
  against bioterrorism are main aspects that are
  predicted to promote industry expansion in
  future.
• Many government legislations like project
  bioshield offers nations with counter measures
  against chemical, radiological, nuclear and
  biological attack.
• Project bioshield assures accessibility of next
  generation medical countermeasures against
  smallpox and anthrax agents. Main goal of the
  project is creating funding authority to build
  next generation counter measures, make innovative
  research development programs and create a body
  like FDA (Food Drug Administration) that can
  effectively use treatments in case of
  emergencies.
• Furthermore, enhanced alertness displayed by
  public health organizations by investing in
  biodefense technology, skilled persons and
  materials along with heavy government support as
  well as funding from private public sectors are
  predicted to contribute towards global biodefense
  market growth.

3
Continued...

• Global biodefense industry is segmented into
  products like botulism, anthrax,
  nuclear/radiation and small pox. Anthrax product
  segment contributed about 31.6 to global
  biodefense market share for 2015 and is projected
  to surpass revenue of 4.21 billion by end of
  forecast timeframe.
• Further, government projects like BioShield,
  BARDA (Biomedical Advanced Research and
  Development Authority) and Joint Program
  Executive Office-Chemical and Biological Defenses
  offer large funding and vaccine doses against
  anthrax.
• Global biodefense market is segmented into
  geographical locations like APAC, Latin America,
  Europe, MEA and North America.
• North America biodefense industry dominated the
  global industry by accounting for highest
  regional revenue share for 2015. It contributed
  about 8.91 billion in terms of revenue for this
  year.
• Key industry participants profiled in the report
  include Emergent Biosolutions, SIGA Technologies,
  Ichor Medical Systems Incorporation,
  PharmaAthene, Cleveland BioLabs Incorporation,
  Achaogen, Alnylam Pharmaceuticals, Xoma
  Corporation, Dynavax Technologies Incorporation,
  Elusys Therapeutics.

4
U.S. Biodefense Market Size, by Product, 2012 -
2024 (USD Million)

5
Table of Content
Chapter 1. Methodology and Scope 1.1.
Research Methodology 1.1.1.
Initial data exploration 1.1.2. Statistical
model and forecast 1.1.3. Industry insights
and validation 1.2. Data
Sources Chapter 2. Executive Summary 2.1.
Biodefense industry 3600 synopsis, 2012 -
2024 2.1.1. Business trends 2.1.2.
Regional trends 2.1.3. Product
trends Chapter 3. Biodefense Industry
Insights 3.1. Industry segmentation 3.2.
Industry Size and forecast, 2012 - 2024
6
Table of Content
3.3. Industry Impact forces 3.3.1. Growth
drivers 3.3.1.1. Presence of favorable
government initiatives 3.3.1.1.1 Project
BioShield Act, 2004 3.3.1.1.2 Emergency Use
Authorization of Medical Products 3.3.2.
Industry pitfalls challenges 3.3.2.1. Low
penetration in developing and underdeveloped
countries 3.4. Growth potential analysis 3.5.
Porters analysis 3.6. PESTEL analysis 3.7
Market Insights, By type 3.7.1 Biological
defense 3.7.2 Chemical defense product
pipeline 3.7.3 Nuclear/ radiation defense
product pipeline
7

Browse Full Market Research Report On Biodefense
Market _at_ http//bit.ly/2pMVKGs Request for
a Sample of this Research Report _at_
https//www.gminsights.com/request-sample/detail/7
31
8
Stay In Touch Website www.gminsights.com Soci
al Media